Varian Associates shareholders last month voted to approve a proposal to split the company into three separate businesses. The Palo Alto, CA, firm’s instruments and semiconductor equipment concerns will be spun off into separate companies, while the
Varian Associates shareholders last month voted to approve a proposal to split the company into three separate businesses. The Palo Alto, CA, firms instruments and semiconductor equipment concerns will be spun off into separate companies, while the remaining healthcare unit will be renamed Varian Medical Systems.
Varians board of directors proposed the split in August in an effort to focus each of its disparate businesses (SCAN 9/2/99). On Feb. 16, the company received notice from the Internal Revenue Service that the agency will allow the split to be treated as a tax-free transaction for shareholders. Two days later, Varians stockholders voted for the split.
Varian Medical Systems will continue to be listed on the New York Stock Exchange and will keep the symbol VAR. The instruments company will be called Varian, and the semiconductor business will be called Varian Semiconductor Equipment Associates.
In other news, Varian X-Ray Tube Products has introduced a series of high-performance CT x-ray tubes. The Quantum Series CT tube is based on an integral housing technology that consolidates three commonly used components of the tube: the element that generates the x-rays, the lead-lined container, and the device that helps cool the tube. Varian plans to market the tubes for use in low-cost CT systems and will begin shipping them early this year.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.